NCT02623738View on ClinicalTrials.gov

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

253

Participants

Timeline

Start Date

December 6, 2015

Primary Completion Date

February 10, 2017

Study Completion Date

February 10, 2017

Conditions

Primary Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

Placebo ophthalmic solution

DRUG

DE-117 ophthalmic solution low

DRUG

DE-117 ophthalmic solution high

DRUG

Latanoprost ophthalmic solution 0.005%

Trial Locations (1)

Unknown

Tokyo, Osaka

All Listed Sponsors

lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY

NCT02623738 - A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- | Biotech Hunter | Biotech Hunter